Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15

Cancer Genetics and Cytogenetics

Volumn 87, Issue 1, 1996, Pages 14-23

  Jackson Cook, Colleen ^b   Bae, Victoria ^c   Edelman, William ^c   Brothman, Arthur ^a   Ware, Joy ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 19; CHROMOSOME TRANSLOCATION 5; CYTOGENETICS; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; Y CHROMOSOME LINKAGE;

EID: 0029913708     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00232-4     Document Type: Article

References (23)

1. Peehl DM (1994): The male reproductive system: Prostatic cell lines. In: Atlas of Human Tumor Cell Lines, eds., Academic Press, New York, pp. 387-411.
2. Kaighn ME, Reddel RR, Lechner JF, Peehl DM, Camalier RF, Brash DE, Saffioti U, Harris CC (1989): Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. Cancer Res 49:3050-3056.
3. Cussenot O, Berthon P, Berger R, Mowszowicz I, Faille A, Hojman F, Teillac P, Le Duc A, Calvo F (1991): Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. J Urol 143:881-886.
4. Bae VL, Jackson-Cook CK, Brothman AR, Maygarden SJ, Ware JL (1994): Tumorigenicity of SV40T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression. Int J Cancer 58:721-729.
5. Rooney DE, Czepulkowski BH (1992): Prenatal Diagnosis and Tissue Culture in Human Cytogenetics, a Practical Approach. Vol I. Oxford University Press, New York, pp. 55-89.
6. Barch MJ (1991): Giemsa-banding technique using trypsin (GTG) in the ACT Cytogenetics Laboratory Manual, 2nd Ed. Raven Press, New York, pp. 221-222.
7. Bae VL, Jackson-Cook CK, Maygarden S, Brothman AR, Chen J, Ware JL (1995): A new model for cytogenetic analysis of human prostate cancer progression and metastasis, Proc AACR 36:642(A).
8. Jackson-Cook CK, Bae VL, Edelman W, Maygarden SJ, Brothman AR, Ware JL (1995): Cytogenetic characterization of tumorigenic and metastatic human prostate cancer cell lines, presented at ACC, Cytogenetic Cell Genet 71(4):397.
9. Sandberg AA (1992): Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 23:368-380.
10. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB (1994): Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54:3998-4002.
11. Zitzelsberger H, Szucs S, Weier H-U, Lehmann L, Braselmann H, Enders S, Schilling A, Breul J, Hofler H, Bauchinger M (1994): Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J Pathol 172:325-335.
12. Bandyk MG, Zhao L, Troncoso P, Pisters L, Palmer JL, von Eschenbach AC, Chung LWK, Liang JC (1994): Trisomy 7: A potential cytogenetic marker of human prostate cancer progression. Genes Chrom Cancer 9:12-27.
13. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi O-P (1994): Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145:624-630.
14. Jones E, Zhu XL, Rohr R, Stephenson RA, Brothman A (1994): Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chrom Cancer 11:163-170.
15. Merlino GT, Ishii S, Whang-Peng J, Knutsen T, Xu YH, Clark AJ, Stratton RH, Wilson RK, Ma DP, Roe BA (1985): Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 5:1722-1734.
16. Visakorpi T, Kallioniemi AH, Syvanen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
17. Van Dekken H, Alers J (1993): Loss of chromosome Y in prostatic cancer cells, but not in stromal tissue. Cancer Genet Cytogenet 66:131-132.
18. Elfving P, Cigudosa JC, Lundgren R, Limon J, Mandahl N, Kristoffersson U, Heim S, Mitelman F (1990): Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cytogenet Cell Genet 53:123-125.
19. Heim S, Mitelman F (1987): Cancer Cytogenetics. Alan R. Liss, New York, p. 90.
20. Cher ML, Takashi I, Weidner N, Carroll PR, Jensen RH (1995): Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153:249-254.
21. Giroldi LA, Schalken JA (1993): Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev 12:29-37.
22. Ray R, Miller DM (1991): Cloning and characterization of a human c-myc promoter-binding protein. Mol Cell Biol 11: 2154.
23. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV (1995): Mutation of the MXI1 gene in prostate cancer. Nature Genet 9:249-255.